Fulcrum Therapeutics (NasdaqGM:FULC) Q1 2026 Earnings call April 27, 2026 08:00 AM ET Company ParticipantsAlan Musso - CFOAlex Sapir - CEO and PresidentIain Fraser - SVP of Clinical DevelopmentConference Call ParticipantsAnupam Rama - AnalystCorinne Johnson - AnalystGregory Renza - AnalystJames Condulis - AnalystJoe Schwartz - AnalystKristen Kluska - AnalystMatthew Biegler - AnalystOperatorGood morning, and welcome to Fulcrum Therapeutics' first quarter 2026 financial results and business update conference ...